// App-Quantinova.ai

1624 : Silencing of ERK2 reverses EMT and suppresses the CSC phenotype, inhibiting lung metastasis in triple-negative breast cancer

Researchers

Presenter

  • Mary Kathryn Pitner

Principal Investigators

  • Hitomi Saso

  • Richard Larson

  • Rachel M. Sammons

  • Huiqin Chen

  • Caimiao Wei

  • Gaurav Chauhan

  • Kimie Kondo

  • Naoto T. Ueno

  • Kevin Dalby

  • Bisrat G. Debeb

  • Chandra Bartholomeusz

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • The University of Texas at Austin, Austin, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Lung Cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Mitogen-activated protein kinase 3

  • Cluster of Differentiation 24

  • Cluster of Differentiation 44

  • Early Growth Response 1

  • Solute Carrier Family 22 Member 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved